Delivery Order SPE2DB20D2014-SPE2DB23FD00U
Award Date 8/8/23
Potential Completion Date 8/9/23
Potential Value $586
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $8,653.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 capsules of 60mg duloxetine hydrochloride. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and DoD customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by September 18, 2023. No set aside provisions or...
- The Defense Logistics Agency awarded a $97,630 delivery order to AmerisourceBergen Drug Corporation for 1,000 capsules of 60mg duloxetine hydrochloride. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania over a three-day period concluding on August 14, 2023. The firm fixed price contract has...
- The Defense Logistics Agency awarded a $18,960 delivery order to Amerisourcebergen Drug Corporation for 90 capsules of 30mg duloxetine hydrochloride. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 24-25, 2023. The fixed-price order was awarded non-competitively...
- The Defense Logistics Agency awarded a $585,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 60mg duloxetine hydrochloride delayed release capsules. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 18, 2023 to support DLA's medical supply chain requirements. No...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $520.20 to Amerisourcebergen Drug Corporation for 1,000 capsules of 60mg duloxetine hydrochloride. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements. The delivery order was issued on August 31, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle managed...
- The Defense Logistics Agency awarded a $38,820 delivery order to Amerisourcebergen Drug Corporation for 90 capsules of 30mg duloxetine hydrochloride. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period. The firm fixed price order is for the supply of a specified generic drug to support...
- The Defense Logistics Agency awarded a $265,040 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 bottles of 60mg duloxetine hydrochloride capsules. The single day order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility to support the Department of Defense's pharmaceutical supply needs. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a $7,749 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 capsules of 60mg duloxetine hydrochloride. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility in support of the Defense Logistics Agency's pharmaceutical procurement programs. No additional details were provided regarding subcontractors or the context of the order within DLA's broader initiatives. The award utilizes commercial item...
- The Defense Logistics Agency awarded a $56,880 delivery order to Amerisourcebergen Drug Corporation for 90 capsules of 30mg duloxetine hydrochloride. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 13-14, 2023. DLA will utilize this purchase of the generic antidepressant/antinociceptive medication to support its medical supply chain operations. No subcontractors or set aside designations were identified in...
- The Defense Logistics Agency awarded a $56,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90-count bottles of 30mg duloxetine hydrochloride capsules. The one-day contract has a period of performance from July 20, 2023 through July 21, 2023, with all work taking place in Conshohocken, Pennsylvania. DLA manages the Department of Defense's global supply chain and supports military treatment facilities and other government agencies. This delivery order for generic...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FD00UDelivery Order
The Defense Logistics Agency awarded a $585.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1000 capsules of 60mg Duloxetine hydrochloride. The delivery order was issued under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 9, 2023. The purpose of this order is to fulfill DLA's requirement for the specified generic drug to support its medical supply chain programs. No subcontractors or set aside designations were identified.
Generated 12/24/23, 4:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $586 | 8/8/23 |